Distress screening in lung cancer.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Lung cancer patients with histological confirmation
- Registration Number
- CTRI/2016/02/006635
- Lead Sponsor
- Tata Memorial Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
1.Treatment naïve Lung cancer patients with histological confirmation of Non-small cell lung cancer(NSCLC) or Small cell lung cancer (SCLC)attending outpatient department of Radiation oncology and planned for radiotherapy.
2.Aware of their diagnosis and treatment plan.
3.Consenting to participate in study.
4.Age >18years.
Exclusion Criteria
1 Patients with diagnosed psychiatric illness.
2 Patients on Antidepressants, Mood stabilizing agents, Antipsychotics.
3 Patients with Acute medical illness needing intensive medical treatment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of Clinically significant distress at base line, first and second follow-up.Timepoint: Proportion of Clinically significant distress at base line, first and second follow-up.
- Secondary Outcome Measures
Name Time Method 1 To evaluate prevalence of significant distress in radically treated Lung cancer patients <br/ ><br>2. To evaluate factors for distress using NCCN problem check list. <br/ ><br>3. To study QOL in patients treated with radical radiation therapy with or without chemotherapy at baseline. <br/ ><br>4. To study the Impact of referral to Psycho-oncology and Palliative care along with definitive treatment in patients with significant distress scores in radically treated patient cohort. <br/ ><br>5. To correlate DT scores with QoL.Timepoint: Proportion of Clinically significant distress at base line, first (Three Month) and second (Six Month) follow-up.